Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Early-onset male baldness may increase the risk of metabolic syndrome.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.